The neuroprotective properties of GLP1R agonists correlate with their ability to cross the bloodbrain barrier
In 2022, the FDA added both semaglutide and tirzepatide to its drug-shortage list
Meta-analyses have shown that the amount of weight regained after stopping treatment is typically proportional to the initial weight loss, and lifestyle interventions become increasingly difficult to maintain once the medication is discontinued ( 10 Expanding the use of GLP-1RAs to treat substance use disorders To date, only a limited number of clinical trials have evaluated the effectiveness of GLP-1RAs for substance use disorders, yet initial findings are encouraging
Therefore, the timing of its consumption can influence the availability of fatty acids for energy, reduction of fatigue, and the speed of recovery after exercise
Fertility Male fertility: Oxidative stress is a major contributor to male infertility, damaging sperm DNA, membranes, and motility
Diabetes, Metabolic Syndrome and Obesity